Olaparib Dose Escalating Trial in Patients Treated With Radiotherapy With or Without Daily Dose Cisplatin for Locally Advanced Non-small Cell Lung Carcinoma
Phase of Trial: Phase I
Latest Information Update: 15 Oct 2015
At a glance
- Drugs Cisplatin; Olaparib
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Biomarker
- 09 Oct 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2020 as reported by ClinicalTrials.gov record.
- 09 Oct 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Nov 2017 as reported by ClinicalTrials.gov record.
- 12 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.